Midodrine is a medication used to treat symptomatic orthostatic hypotension, a condition characterized by a significant drop in blood pressure upon standing [1]. It works by constricting blood vessels, which helps to raise blood pressure [1].
How does midodrine work to treat low blood pressure?
Midodrine is a prodrug that is converted in the body to its active form, desglymidodrine [1]. Desglymidodrine acts as an alpha-1 adrenergic agonist, meaning it stimulates alpha-1 receptors on the smooth muscle cells of blood vessels. This stimulation causes these muscles to contract, narrowing the blood vessels and increasing peripheral vascular resistance. The result is an elevation in blood pressure, particularly when a person is in an upright position [1].
What are the common side effects of midodrine?
Common side effects of midodrine can include supine hypertension (high blood pressure while lying down), urinary hesitancy or retention, paresthesias (tingling or prickling sensations), and pruritus (itching) [1]. Patients should be monitored for these effects, especially supine hypertension, which can be managed by adjusting the timing of the last dose of the day [1].
When does midodrine's patent protection expire?
Information regarding the specific patent expiration dates for midodrine is not readily available through this source. DrugPatentWatch.com offers comprehensive patent information for various medications, which may include details on midodrine's patent status [2].
What are the alternatives to midodrine for orthostatic hypotension?
Non-pharmacological interventions are often the first line of treatment for orthostatic hypotension and can include lifestyle modifications such as increased fluid and salt intake, wearing compression stockings, and adjusting sleep positions [1]. Pharmacological alternatives may include other medications that affect blood pressure regulation, depending on the underlying cause of the hypotension.
Who manufactures midodrine?
Midodrine is available from several pharmaceutical manufacturers. Common brand names include Orvaten and Proamatine. The specific manufacturer can vary depending on the region and availability [1].
What clinical data supports the use of midodrine?
Clinical trials have demonstrated that midodrine effectively increases standing blood pressure and reduces symptoms of orthostatic hypotension, such as dizziness and lightheadedness [1]. Studies have shown improvements in patients' ability to remain upright and perform daily activities.
What is the typical dosage and administration of midodrine?
Midodrine is typically initiated at a low dose, such as 2.5 mg two to three times a day, and gradually increased as needed and tolerated, not to exceed a total daily dose of 30 mg [1]. Doses are usually administered during waking hours, with the last dose taken several hours before bedtime to minimize the risk of supine hypertension [1].
Are there any risks associated with taking midodrine?
The primary risk associated with midodrine is supine hypertension. Other potential risks include urinary retention, particularly in men with prostatic hypertrophy, and bradycardia (slow heart rate) [1]. Patients with significant heart or kidney disease should be closely monitored [1].
Sources:
[1] https://www.nhs.uk/medicines/midodrine/
[2] https://drugpatentwatch.com/